Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 3Inflammation 2Frailty 2Small Cell Lung Carcinoma 1Radiodermatitis 1Prostatic Neoplasms 1Papillomavirus Infections 1Low-Grade Intraepithelial Neoplasia of Cervix 1Liver Neoplasms 1Liver Cirrhosis 1Fibrosis 1Esophageal Neoplasms 1Deglutition Disorders 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 9Papillomavirus Vaccines 8Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 8Surveys and Questionnaires 6Educational Status 6Blood Specimen Collection 5Vaginal Smears 4Radiotherapy, Intensity-Modulated 4Methods 4Human Papillomavirus DNA Tests 4Early Intervention, Educational 4Cisplatin 4Carboplatin 4Patient Navigation 3Mass Screening 3Taxes 2Standard of Care 2Radiation 2Practice Guidelines as Topic 2Papanicolaou Test 2Paclitaxel 2Motivational Interviewing 2Interviews as Topic 2Electrocoagulation 2Docetaxel 2Cytological Techniques 2Cryotherapy 2Colposcopy 2utomilumab 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Papillomavirus Infections × epigallocatechin gallate × Clear all
NCT06661083 2025-03-19

The Effect of Natural Molecules on HPV Infection

AGUNCO Obstetrics and Gynecology Centre

Phase NA Completed
106 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡